The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
They have had this problem for years now with Barclays. I thought it had been sorted though.
A quote from Belluscura.
We cannot guarantee anything, but it is our expectation that with our patent portfolio, the key market differentiating factors of the X-PLOR, and our pipeline of technology that an IPO or exit event is likely to occur within a fairly short period of time. Some key factors that will drive that timeline include FDA clearance timing
Monthly circulars. Lol. It’s been a farce. I invested over 2 years back with a valuation of £4m. From what I can make of it, only my opinion... is that they list later this year, which will give them the funds to ramp up their production...as well as themselves. Lol.
The NAV is the current estimate of the value of the company as they aren’t listed holdings. The reason you usually get a big discount on private equity is .... if you tried to cash everything in today ....could you actually get that full value ???
I held this years back and got out after months of no no movement and seemingly every other week they seemed to add people on the books - jobs for the boys. I got back in under 5p and sold again at 14p as I thought it was quite highly valued at that price. I bought in at around 10p and do believe it’s worth a lot more - not sure if it’s worth it’s full 25p but I do believe maybe 18 - 20. Their accounting is often misleading to others too. Over the years they have shown what excellent profits ....when in fact it was big losses ...only shown as profits because they raised their own NAV. Same as revenue ...its actually 1m. The rest is due to them increasing their own NAV. When one of the holdings is sold or lists it might create an uplift. Until then it’s do you believe the valuation.
I’ve bought and sold this for over 5 years now. For all the share price is about the same as when I started I have probably more than doubled my money in FFwd over the years with its typical peaks and troughs. I’ll probably sell once Leap is sold and maybe Juv or Yoom gives a return. I’m only really interested in private equity, not really bothered about a cannabis fund.
Barwickman. No. My mistake. It is $4.5m dollars into Leap. Not pounds. It was $3.5m and 950k euros -$4.5m.
I hope so. I think many are banking on this one. There hasn’t been that much success so far. Surely they can’t go wrong with Leap. Like they did with moon
Jimzi. Doggo is just highlighting how Leap isn’t factored into the price. The current NAV. Is 11.25p Leap is on the books at £7.5m currently.
Go ahead doggo. Guess !! I’m thinking £50m for Leap valuation.
I’ve been investing in private equity for many years through links with people who earn more in a month than I earn in a year. The high risk / reward expectation has increased hugely over the years so much so that a company who we recently invested in running a pitch expecting a 3 fold return in around 18 months also ran a 12month follow on investment with a guaranteed 15% return in just one year, total guarantee not just hopes. Less than 10% of those offered it actually invested with them. They all thought they could get better returns in other ventures, crazy, greedy?? Ffwd have been with Leap well over 4 years and have invested around £4.5m. If FFWD don’t get over £20m back for their share I would really be disappointed.
Lol. Like FFWD did recently.